NuStar GP Holdings, LLC (NSH) Given Consensus Rating of “Hold” by Analysts

NuStar GP Holdings, LLC (NYSE:NSH) has earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $22.33.

Several equities research analysts have weighed in on NSH shares. Barclays lowered their target price on NuStar GP from $22.00 to $21.00 and set an “equal weight” rating for the company in a report on Wednesday, November 8th. Zacks Investment Research upgraded NuStar GP from a “sell” rating to a “hold” rating in a report on Wednesday, November 15th. UBS Group lowered their target price on NuStar GP from $33.00 to $21.00 and set a “buy” rating for the company in a report on Wednesday, October 18th. Mizuho reiterated a “hold” rating and issued a $25.00 target price on shares of NuStar GP in a report on Friday, October 20th. Finally, Citigroup upgraded NuStar GP from a “neutral” rating to a “buy” rating and set a $17.00 target price for the company in a report on Tuesday, December 5th.

Shares of NuStar GP (NYSE NSH) traded up $0.20 during mid-day trading on Friday, hitting $17.80. The company’s stock had a trading volume of 123,485 shares, compared to its average volume of 363,447. NuStar GP has a twelve month low of $13.50 and a twelve month high of $31.50. The stock has a market cap of $764.54, a PE ratio of 8.94 and a beta of 1.02.

NuStar GP (NYSE:NSH) last issued its earnings results on Tuesday, November 7th. The pipeline company reported $0.26 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.34 by ($0.08). NuStar GP had a return on equity of 23.17% and a net margin of 178.06%. equities analysts anticipate that NuStar GP will post 2.1 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BNP Paribas Arbitrage SA bought a new position in shares of NuStar GP in the 3rd quarter worth $103,000. Alliancebernstein L.P. raised its position in shares of NuStar GP by 5.9% in the 2nd quarter. Alliancebernstein L.P. now owns 8,841 shares of the pipeline company’s stock worth $216,000 after acquiring an additional 495 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of NuStar GP in the 2nd quarter worth $237,000. Virtu KCG Holdings LLC bought a new position in shares of NuStar GP in the 2nd quarter worth $246,000. Finally, WFG Advisors LP raised its position in shares of NuStar GP by 13.9% in the 2nd quarter. WFG Advisors LP now owns 12,300 shares of the pipeline company’s stock worth $301,000 after acquiring an additional 1,500 shares in the last quarter. 55.57% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This story was originally published by American Banking News and is the property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/20/nustar-gp-holdings-llc-nsh-given-consensus-rating-of-hold-by-analysts.html.

About NuStar GP

NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.

Analyst Recommendations for NuStar GP (NYSE:NSH)

Receive News & Ratings for NuStar GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuStar GP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply